Online auction company eBay Inc. will have a stab at reversing a $29.5 million judgment when it returns to federal court Tuesday to appeal a patent-infringement in favor of rival MercExchange LLC.
Pfizer Inc. will file an official appeal Tuesday against a decision by China's State Intellectual Property Office to overturn the U.S. drug maker’s patent for erectile-dysfunction drug Viagra, the Wall Street Journal’s Asian edition reported.
Infosys, one of India’s top information technology companies, is going to the country’s Supreme Court to fight off a challenge to the company’s well-known trademark.
The U.S. Court of Appeals for the Federal Circuit’s landmark Knorr-Bremse ruling won’t hurt opinion practices at boutique firms, the president of the Association of Patent Law Firms insisted.
The U.S. Court of Appeals for the Federal Circuit has ruled that Scientific-Atlanta infringed on a patent held by Gemstar-TV Guide International, overturning a decision by the ITC.
In a landmark decision that could erode patent-opinion work at boutique intellectual-property firms, a panel of eleven judges at the U.S. Court of Appeals for the Federal Circuit has ruled that no adverse inference should flow from a party's refusal to present an exculpatory opinion of counsel.
The U.S. Court of Appeals for the Federal Circuit has affirmed a summary judgment in EchoStar's favor that said the company did not infringe a patent held by Irdeto Access, formerly known as TV/Com International.
Generics maker Alpharma Inc. has asked an appeals court to lift its order to stay the U.S. Food and Drug Administration’s final approval of the company’s generic version of Pfizer's epilepsy treatment Neurontin.
In a decision that affirms no infringer is immune from a trademark challenge because of its size, a federal appeals court has ordered one of the largest banks in the U.S. to change the name of its branches in parts of Pennsylvania to avoid infringing on the trademark of a much smaller but older competitor.
Danish drug maker Novo Nordisk has decided to appeal a court decision that rendered its patent for recombinant human growth hormone invalid and unenforceable due to inequitable conduct at the U.S. Patent and Trademark Office.
The U.S. 9th Circuit Court of Appeals has overturned the lion’s share of a $2.4 million jury verdict against watch maker Timex Corp in a copyright and trademark infringement lawsuit brought by Polar Bear Productions Inc.
The U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of infringement of three National Instruments patents by Massachusetts-based The MathWorks, Inc. and found a fourth patent valid but not infringed.
Dutch chip equipment maker ASML and Japanese rival Nikon have settled their costly and long-running patent dispute over circuit-making equipment, fought in courts in California, Washington, South Korea and Japan.
In a closely watched test of the Digital Millennium Copyright Act, the U.S. Court of Appeals for the Federal Circuit has upheld a lower court’s ruling that a garage-door opener designed as a replacement for a model made by a rival manufacturer does not violate the DMCA.
The U.S. Court of Appeals for the Federal Circuit has granted Guidant Corp. a new trial in its patent dispute with St. Jude Medical Inc. over implantable defibrillators, but denied a Guidant request to simply reinstate the $140 million jury verdict that was thrown out by the trial judge in Indiana district court.
The U.S. Court of Appeals for the Federal Circuit has partially upheld a lower court’s verdict in a case about a technique used to mold plastic tail light lenses on more than 30 different Japanese cars sold in the U.S.
The U.S. Patent and Trademark Office acted appropriately in rejecting a patent application because a description of the invention was posted at a billboard at a public meeting a year earlier, the U.S. Court of Appeals for the Federal Circuit has determined.
In a major setback for the entertainment industry, a federal appeals court in California has ruled that online file-sharing software companies are not liable for copyright infringement.
The U.S. Court of Appeals for the Federal Circuit has affirmed a district court jury's finding that Dorel Industries’ Safety 1st unit infringed two patents held by toymaker Mattel Inc.’s Fisher-Price unit, and said another product should be considered when a new jury calculates damages.
A federal judge has ruled that the U.S. Food and Drug Administration (FDA) acted appropriately in withdrawing its final approval of Mylan Laboratories's Abbreviated New Drug Application (ANDA) for its generic version of Alza Corp.’s Duragesic, a painkiller delivered to the skin through a patch.